Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (ENGOT-ov60/GOG-3052/RAMP 201):
Dose Intensity and Subgroup Analysis
Dr. Abdulhameed Alfagih
Speaker
Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer (ENGOT-ov60/GOG-3052/RAMP 201):
Dose Intensity and Subgroup Analysis